Toprol XL overdosage: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Metoprolol succinate#Overdosage]]
{{Metoprolol}}
{{CMG}}
 
'''Signs and Symptoms''' – Overdosage of TOPROL-XL may lead to severe [[bradycardia]], [[hypotension]], and [[cardiogenic shock]]. Clinical presentation can also include: [[atrioventricular block]], [[heart failure]], [[bronchospasm]], [[hypoxia]], impairment of consciousness/[[coma]], [[nausea]] and [[vomiting]].
 
'''Treatment''' – Consider treating the patient with intensive care. Patients with [[myocardial infarction]] or [[heart failure]] may be prone to significant [[hemodynamic instability]]. Seek consultation with a regional poison control center and a medical toxicologist as needed. [[Beta-blocker]] overdose may result in significant resistance to resuscitation with adrenergic agents, including beta-agonists. On the basis of the pharmacologic actions of metoprolol, employ the following measures.
 
There is very limited experience with the use of hemodialysis to remove metoprolol, however metoprolol is not highly protein bound.
 
'''Bradycardia''': Administer intravenous [[atropine]]; repeat to effect. If the response is inadequate, consider intravenous [[isoproterenol]] or other positive [[chronotropic]] agents. Evaluate the need for transvenous [[pacemaker]] insertion.
 
'''Hypotension''': Treat underlying [[bradycardia]]. Consider intravenous vasopressor infusion, such as [[dopamine]] or [[norepinephrine]].
 
'''Bronchospasm''': Administer a [[beta2]]-agonist, including [[albuterol]] inhalation, or an oral [[theophylline]] derivative.
 
'''Cardiac Failure''': Administer [[diuretic]]s or [[digoxin]] for [[congestive heart failure]]. For [[cardiogenic shock]], consider IV [[dobutamine]], [[isoproterenol]], or [[glucagon]].<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TOPROL XL (METOPROLOL SUCCINATE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01038198-b4f0-41f3-9a9c-5c84e5a0d3b9 | publisher =  | date =  | accessdate = }}</ref>
 
==References==
 
{{Reflist}}
 
{{FDA}}
 
[[Category:Antianginals]]
[[Category:Antiarrhythmic agents]]
[[Category:Antihypertensive agents]]
[[Category:Antimigraine drugs]]
[[Category:Beta blockers]]
[[Category:Cardiovascular Drugs]]

Latest revision as of 03:41, 22 July 2014